Georgia Medicare Kickback Sentencing & FDA Updates on Lead Cookware and Primate Testing
Georgia man sentenced for $24M Medicare genetic testing kickback scheme; FDA warns on lead in cookware; new guidance limits primate testing in drug development.
US Congress Advances Healthcare Legislation; FDA Launches Agentic AI; CMS Updates Payments
Overview of US Congressional healthcare legislation, FDA's AI modernization, CMS payment reforms, and key trade agreements influencing the insurance landscape in 2025.
2025 Changes in COVID-19 Vaccine Eligibility and Off-label Use in the U.S.
Explore the 2025 U.S. updates on COVID-19 vaccine eligibility, off-label use, and insurance coverage ensuring broad access amid regulatory changes.
FDA Approves Leucovorin for Autism Amid Investment and Regulatory Clarifications
FDA approves prescription leucovorin for autism treatment; HHS addresses investment and regulatory concerns involving CMS administrator Dr. Mehmet Oz amid public discourse.
US 2025-26 Flu Season Vaccination Guidance and Insurance Coverage Update
Explore expert insights on the 2025-26 US flu vaccine updates, CDC recommendations, insurance coverage, and vaccine policy changes affecting the flu season.
Supreme Court Procedural Rulings Favor Corporate Access to Federal Courts
Recent Supreme Court procedural rulings lower barriers for corporate lawsuits, enabling strategic venue choices and expanded standing, impacting environmental and FDA regulatory challenges in U.S. federal courts.
FDA Updates COVID Vaccine Policy; Medicare Fraud Sentencing; Immunization Funding Growth
FDA refocuses COVID vaccine approvals on high-risk groups with new evidence requirements. Medicare fraud case results in sentencing for $3.2M scheme. Lower-income countries increase self-funded vaccine investments. Bipartisan prior authorization reform bill returns in Congress.
FDA Approves First Blood Test to Aid Alzheimer’s Diagnosis
The FDA has approved Lumipulse, the first blood test for Alzheimer's diagnosis in symptomatic older adults, enabling less invasive detection of amyloid plaques and supporting earlier, accurate diagnosis and treatment options.
U.S. Health Policy Update: Autism Research, Drug Pricing, HHS Cuts, and Preventive Care Coverage
Insights on recent shifts in U.S. health policy: autism research, drug pricing reforms, HHS operational cuts, abortion access, and legal challenges to insurance preventive care coverage.
Novo Nordisk Seeks FDA Approval for Oral Anti-Obesity Drug Amid GLP-1 Market Competition
Novo Nordisk applies for FDA approval of oral anti-obesity drug following Eli Lilly's clinical success, intensifying competition in the GLP-1 diabetes and weight loss market.